Juvenile myoclonic epilepsy as a spectrum disorder: A focused review

Since the first, impressively comprehensive description by Janz and Christian [1] juvenile myoclonic epilepsy (JME) has appeared as a well-shaped disease entity. The name-giving seizure type, indispensable for the diagnosis, was single or arrhythmic bilateral, predominantly brachial myoclonus, that could be combined with generalized tonic-clonic seizures (GTCS), mostly in the awakening phase, and absences [2]. Traditionally, JME is considered an idiopathic generalized epilepsy [2]. However, this concept is not accepted any more, but being replaced by a view focusing on ...

Seguir leyendo →
0

Welfare consequences for people with epilepsy and their partners: A matched nationwide study in Denmark

Epilepsy is a common and chronic neurological disorder affecting approximately 1% of people of all ages [1,2]. Despite diagnostic and therapeutic improvements, refractory epilepsy is relatively frequent and, due to significant comorbidity, is still one of the most common serious brain disorders worldwide. Epilepsy is associated with social stigma, psychosocial adversities, and reduced quality of life for patients and their caregivers and, thus, has a substantial socioeconomic impact [3–6].

Seguir leyendo →
0
Página 3 de 26 12345...»